Van beleggers
voor beleggers
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?
Home  /  Forum  /  Amerikaanse aandelen  /  MMTC Micro Imaging Technology.inc OTC QB

Ontvang nu dagelijks onze kooptips!

word abonnee

Amerikaanse aandelen« Terug naar discussie overzicht

MMTC Micro Imaging Technology.inc OTC QB

63 Posts
Pagina: «« 1 2 3 4 »» | Laatste | Omlaag ↓
  4. [verwijderd] 18 augustus 2011 19:29
    Hi folks,
    Ik ga niet verkondigen dat het beter is om in Amerikaans fondsen en bedrijven te beleggen, maar ik ben blij dat ik geen nederlandse aandelen bezit op dit moment. Wat een drama, mischien goedkoop inkopen?
    Met MMTC gaat het momenteel niet slecht, ik kom steeds dichter bij break even en laten we hopen dat het nog wat verder stijgt, good luck to everyone.
  7. welshterrier 5 18 augustus 2011 21:37


    Public Reply | Private Reply | Keep | Last Read Post New Msg Previous | Next

    Stocktamer Share Thursday, August 18, 2011 3:35:07 PM
    Re: None Post # of 14031

    Micro Imaging Technology Expands the EPIC Alliance -- Receives Initial Purchase Order

    SAN CLEMENTE, CA, Aug 18, 2011 (MARKETWIRE via COMTEX) -- Micro Imaging Technology, Inc. (OTCBB: MMTC) (OTCQB: MMTC) announced on July 26, 2011 that it has entered into a significant long-term equity alliance with EPIC Corporation (OTC: EPOR). Further details are now available: Principals of EPIC have made personal investments in an MMTC Convertible Debenture and EPIC has entered into an MIT Stock Purchase Agreement. Additionally, EPIC has formed a wholly-owned subsidiary, EPIC Healthcare Systems, Ltd., for the explicit purpose of providing a sales channel for all MIT products -- which are currently only focused at food safety applications. EPIC is committed to expand MIT's capabilities into additional markets, including diagnostic and clinical processes, water and beverage quality control and environmental and clean room monitoring.
    Mr. Ronald Tucker, EPIC's CEO, stated, "EPIC is preparing a program to purchase MIT's hardware and license MIT's software libraries that can currently detect, almost instantly, many different types of bacterium and believe that within the next year over thirty systems will be sold, generating in excess of $1 million in initial revenue to be followed by recurring software licensing fees, support agreements and sales of consumable products. As an additional reinforcement of our commitment to MIT we have also ordered five MIT 1000 Systems for immediate delivery in a transaction roughly valued at $200,000."

    Mr. Michael Brennan, MIT's Chairman, said, "We are very appreciative of EPIC's initial order. Also, as previously stated, this agreement with EPIC will provide us with needed funding now that we have emerged from our development stage and a partner that is very familiar with the healthcare industry. This will enable MIT to approach other markets in healthcare in addition to our current exclusive focus on the $3.5 billion food safety segment."

    ABOUT MICRO IDENTIFICATION TECHNOLOGIES:

    MIT is a California-based public company that has developed and patented a Microbial Identification System that revolutionizes the pathogenic bacteria diagnostic process and can annually save thousands of lives and tens of millions of dollars in health care costs. The System identifies bacteria in minutes, not days, and at a significant per test cost savings when compared to any other conventional method. It does not rely on chemical or biological agents, conventional processing, fluorescent tags, gas chromatography or DNA analysis. The process requires only clean water and a sample of the unknown bacteria. Revenues for all rapid testing methods exceed $5 billion annually -- with food safety accounting for over $3.5 billion, which is expected to surpass $4.7 billion by 2015 according to BCC Research. In addition, the recently passed "New" U.S. Food Safety Bill is expected to further accelerate the current annual growth rate of 6.6%.

    MIT previously completed an extensive evaluation by the AOAC RI Institute which included rigorous independent testing and thorough reviews by its expert examiners, including the U.S. Department of Agriculture. The AOAC RI Report is available from the Company. www.aoac.org

    MIT has also demonstrated the ability to detect and identify, within several minutes, the microbes Escherichia coli, Listeria, Salmonella, Staphylococcus aureus, MRSA and other pathogenic bacteria. MIT recently performed over 300 tests for the identification of these contaminants and scored 95% accuracy. The System can currently identify 23 species of bacteria and its capabilities are easily expanded. The identification process has been verified by North American Science Associates, Inc. (NAMSA), an independent and internationally recognized microbiological testing laboratory. The NAMSA Test Report is available from the Company and, in MIT's opinion, demonstrates the accuracy, speed and cost effectiveness of the System over conventional processes. www.namsa.com

    This release contains statements that are forward-looking in nature. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions are forward-looking statements. These statements are made based upon information available to the Company as of the date of this release, and we assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Factors that could cause or contribute to such differences include, but are not limited to dependence on suppliers; short product life cycles and reductions in unit selling prices; delays in development or shipment of new products; lack of market acceptance of our new products or services; inability to continue to develop competitive new products and services on a timely basis; introduction of new products or services by major competitors; our ability to attract and retain qualified employees; inability to expand our operations to support increased growth; and declining economic conditions, including a recession. These and other factors and risks associated with our business are discussed from time to time within our filings with the Securities and Exchange Commission, reference MMTC: www.sec.gov.
  8. welshterrier 5 18 augustus 2011 21:56


    MMTC~ They have money..

    Mr. Ronald Tucker, EPIC's CEO, stated, "EPIC is preparing a program to purchase MIT's hardware and license MIT's software libraries that can currently detect, almost instantly, many different types of bacterium and believe that within the next year over thirty systems will be sold, generating in excess of $1 million in initial revenue to be followed by recurring software licensing fees, support agreements and sales of consumable products. As an additional reinforcement of our commitment to MIT we have also ordered five MIT 1000 Systems for immediate delivery in a transaction roughly valued at $200,000."

    Mr. Michael Brennan, MIT's Chairman, said, "We are very appreciative of EPIC's initial order. Also, as previously stated, this agreement with EPIC will provide us with needed funding now that we have emerged from our development stage and a partner that is very familiar with the healthcare industry. This will enable MIT to approach other markets in healthcare in addition to our current exclusive focus on the $3.5 billion food safety segment."
  10. [verwijderd] 19 augustus 2011 13:02
    Small-Cap Tech Stock Highlight for Micro Imaging Featured on MicroStockProfit.com
    Date : 08/19/2011 @ 6:50AM
    Source : GlobeNewswire Inc.
    Stock : (MMTC)
    Quote : 0.0098 0.0 (0.00%) @ 2:06AM


    Small-Cap Tech Stock Highlight for Micro Imaging Featured on MicroStockProfit.com
    Tweet print
    Micro Imaging Tech (QB) (USOTC:MMTC)
    Intraday Stock Chart
    Today : Friday 19 August 2011

    MicroStockProfit.com announces a stock report featuring Micro Imaging Technology Inc. (Pink Sheets:MMTC). The report briefly notes the company's most recent developments and news, and outlines its financial position, market performance, and comparison against industry peers.

    The full report is available at: www.microstockprofit.com/lp/MMTC

    Micro Imaging Technology (MMTC), is a California-based company that has developed and patented a system that revolutionizes the pathogenic bacteria diagnostic process and can annually save thousands of lives and tens of millions of health care costs. The Company's Rapid Microbial Identification System identifies bacteria in minutes, not days, and at a significant per test cost savings when compared to any conventional method. It does not rely on chemical or biological agents, conventional processing, fluorescent tags, gas chromatography or DNA analysis. The process is totally green requiring only clean water and a sample of the unknown bacteria. The Company believes that revenues for all rapid testing methods exceed $5 billion annually, with food safety accounting for over $3.5 billion.

    This newsletter has been helping traders make great investment decisions on MMTC; click here for a 25% discount offer.

    In the report, the analyst notes:

    "Late last month, the California-based company issued a press release announcing its long-term equity alliance with EPIC Corp. The report said EPIC has committed to purchasing a substantial equity position in MMTC and, as a health care products supplier, will receive the benefits of MMTC's revolutionary technology.

    "The Company is in the process of preparing the MIT 1000 System for further certifications for the identification of both Salmonella and E. coli later this year."

    To read the entire report visit: www.microstockprofit.com/lp/MMTC

    See what investors are saying about MMTC at www.stockhideout.com

    Get breaking news on MMTC at thestockmarketwatch.com/

    MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on MicroStockProfit please visit: www.microstockprofit.com

    MicroStockProfit.com Disclosure

    MicroStockProfit.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.

    CONTACT: Jay Geller
    info@microstockprofit.com
    1-888-307-2850
  11. welshterrier 5 20 augustus 2011 14:02


    We were at .14 cents awhile back and we now have a global distribution network with soon to be 22 bacterial approved tests, pennies per test, Master distributor with 900,000 in liscensing fees this year, the dutchess financing for shares, the EPIC Alliance for master distributor, and the list goes on and on. This disruptive technology will be used in many other applications soon other than the food service industry. Every lab and hospital will have a machine to identify the bacteria and I would bet that colleges will have classes similiar to the ultrasound technology soon.

    Can you tell I'm pumped!
  12. welshterrier 5 24 augustus 2011 09:04

    This is the reason why I believe the MIT 1000 is almost guaranteed to receive certification for E. Coli and Salmonella:

    The following is an abstract from a study done on the MIT 1000 by the USDA.

    Title: Rapid Confirmation of Listeria spp. with the MIT 1000 Microbial Identification System

    Authors
    item GEHRING, ANDREW
    item PAOLI, GEORGE
    item Koh, Youngho - KOREA FOOD & DRUG ADMIN,
    item Ricardi, John - MICRO IMAGING TECH., CA
    item Haavig, David - MICRO IMAGING TECH., CA

    Submitted to: Meeting Abstract
    Publication Type: Abstract
    Publication Acceptance Date: October 5, 2008
    Publication Date: N/A

    Technical Abstract: Methods that can rapidly confirm the identification of foodborne pathogens are highly desired. The USDA has recently entered into a collaborative research agreement with Micro Imaging Technology to evaluate their MIT 1000 microbial identification system for its ability to identify Listeria species including the human pathogen, Listeria monocytogenes. The MIT 1000 is a benchtop instrument that detects laser light (660 nm, 30 mW, 100 'm diameter) scattered from individual bacterial cells, in aqueous suspension, with an array of 35 individually addressed photodiode detectors. Identification is based upon pattern recognition by the automated algorithm-based comparison of averaged scattered light signal and bacteria scatter pattern libraries. Identification times are less than 10 min (often ca. 5 min) and operating costs are extremely low since the detection procedure requires no reagents (e.g., external labels or tags) other than filtered water. Cursory investigations at a USDA research lab have demonstrated the MIT 1000 to have an accuracy of 100% (n=10-30 per species) for the identification of all Listeria spp. with the exception of L. seeligeri. L. seeligeri was only identified with an accuracy of 10% and the reason for this anomaly is currently unknown. Initial attempts at false positive testing have resulted in 0% of incidence for Citrobacter freundii, Brocothrix thermospacta II, Salmonella enterica serovar Typhimurium, Escherichia coli K12, and multiple strains of E. coli O157:H7. However, a 50% false positive rate was observed for Aeromonas hydrophila when tested against the Listeria spp. library. With further development, the MIT 1000 appears to hold promise for use by food producers and regulatory agencies in the microbial testing of foods.

    www.ars.usda.gov/research/publication...

    Initial attempts at false positive testing have resulted in 0% of incidence for Citrobacter freundii, Brocothrix thermospacta II, Salmonella enterica serovar Typhimurium, Escherichia coli K12, and multiple strains of E. coli O157:H7...

    I would like to know what other machine is capable of testing 0% for false positives? Answer: No other machine that I know of, and believe me, I've been around a variety of testing methods for microbes. To add, this study was done back in 2008; by now, the MIT 1000 is a lot more accurate than it ever was back then. The certifications for E. coli and Salmonella at this point are a given, its a matter of WHEN we'll receive the PR about the certs being approved, not a case of IF.
  18. welshterrier 5 12 oktober 2011 18:33
    Micro Imaging Technology Announces a Date for Its Annual General Shareholders Meeting
    print

    Micro Imaging Technology, Inc. (OTCBB: MMTC) (OTCQB: MMTC) announced today that the Company's Annual General Meeting of Shareholders will be held at MIT's offices located at 970 Calle Amanecer, Suite F, San Clemente, CA 92673 on Wednesday, November 30, 2011 at 10:00 AM (PST) following the U.S. Securities and Exchange Commission ("SEC") approval of its October 11, 2011 Schedule 14A Filing -- Information Required in a Proxy Statement. Although there will be a mailing to all shareholders of record including a Proxy Ballot by the Company's transfer agent, American Stock Transfer and Trust ("AST&T"), the complete Proxy Statement and Annual Report on Form 10-K/A (Amendment No. 1) can be viewed at the Company's web site www.micro-imaging.com or within MMTC's 14A filing with the SEC; referencing MMTC: www.sec.gov.

    The Company is asking its shareholders to vote on two proposals:

    1) To elect two (2) Directors to the Company's Board of Directors, each to serve a term of one year and until their respective successors have been elected and qualified, or until their earlier resignation or removal. The Board of Directors has nominated for election to the Board: Michael W. Brennan and Victor A. Hollander, respectively the Company's Chairman and Chief Financial Officer; and the second and third largest shareholder.

    2) To approve an amendment to the Company's Articles of Incorporation increasing the total number of authorized shares from 500,000,000 to 2,500,000,000.

    With respect to the election of two Directors, Chairman Michael Brennan stated that, "Over the course of the next several months the Company is committed to increasing the size of the Board by adding at least two new Directors which will assist in guiding the Company as it enters its production stage."

    Commenting on the request to increase the authorized number of shares, the Company's Chief Financial Officer Victor Hollander noted that, "The Company's development stage, which commenced in November 2005, has required almost $16 million in funding which has been provided from a variety of equity sources, including continual purchases of Common Stock by the Company's three largest shareholders. Consequently, as we prepare to launch our products in a $5 billion market, we must in the near term still be reliant on equity funding."

  19. [verwijderd] 13 oktober 2011 12:18
    Our directors and executive officers are as follows:

    Michael W. Brennan, age 68, Director (Chairman) and Chief Executive Officer
    Ralph W. Emerson, age 64, Director
    Victor A. Hollander, age 78,Director and Chief Financial Officer

    Michael Brennan/CEO 2010 salary: $180,000
    Victor Hollander/CFO 2010 salary: $120,000

    ih.advfn.com/p.php?pid=nmona&arti...
63 Posts
Pagina: «« 1 2 3 4 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Indices

AEX 918,72 -0,64%
EUR/USD 1,0706 0,00%
FTSE 100 8.146,86 -0,21%
Germany40^ 18.004,30 -1,43%
Gold spot 2.332,68 0,00%
NY-Nasdaq Composite 17.688,88 +0,12%

Stijgers

EVS
+2,37%
SHURGARD
+1,84%
UCB
+1,40%
arGEN-X
+0,64%
Orange...
+0,41%

Dalers

SYENSQO
-4,05%
Solvay
-3,12%
Deceun...
-2,89%
Umicore
-2,85%
Barco
-2,67%

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links

Meld u aan voor de dagelijkse Beursupdate

Dagelijks een update van het laatste beursnieuws en beleggingskansen in uw mailbox!